Invitrogen Partnering With Lentigen to Develop New Gene Expression Products

Aug 04, 2008

NEW YORK (GenomeWeb News) – Invitrogen announced today that it will work with Maryland-based biotechnology company Lentigen to develop and market products and services for gene over-expression based on Lentigen’s lentiviral gene delivery technology and Invitrogen’s human gene collections and cloning and gene synthesis technologies.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Last of the Northern White Rhinoceroses, Sequenced

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

DNA Phenotyping Allowed in Bavaria

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Thanks for the Stress, Dad

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

This Week in Science

In Science this week: gut microbiome influences liver cancer growth, spread; and more.

Main menu